Cargando…
CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma
PURPOSE: Chemokine (C-Cmotif) ligand 2 (CCL2) is a major chemokine that recruit monocytes and macrophages to the sites of inflammation. Recent researches have clarified that overexpression of CCL2 is associated with unfavorable prognosis in various cancer types. In this study, we aim to determine th...
Autores principales: | Wang, Zewei, Xie, Huyang, Zhou, Lin, Liu, Zheng, Fu, Hangcheng, Zhu, Yu, Xu, Le, Xu, Jiejie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239494/ https://www.ncbi.nlm.nih.gov/pubmed/27409666 http://dx.doi.org/10.18632/oncotarget.10492 |
Ejemplares similares
-
High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients
por: Fu, Hangcheng, et al.
Publicado: (2016) -
Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma
por: Xie, Huyang, et al.
Publicado: (2016) -
High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma
por: Xu, Zhiying, et al.
Publicado: (2016) -
Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma
por: Liu, Zheng, et al.
Publicado: (2017) -
High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma
por: Zhang, Haijian, et al.
Publicado: (2017)